GTHX Insider Trading

Insider Ownership Percentage: 8.23%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $397,880.45

G1 Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at G1 Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

G1 Therapeutics Share Price & Price History

Current Price: $4.49
Price Change: Price Increase of +0.02 (0.45%)
As of 03/28/2024 12:39 PM ET

This chart shows the closing price history over time for GTHX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

G1 Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2024John W V UmsteadCFOSell6,547$3.02$19,771.94123,896View SEC Filing Icon  
2/12/2024Rajesh MalikInsiderSell28,600$4.62$132,132.00169,938View SEC Filing Icon  
1/4/2024John W V UmsteadCFOSell111$2.94$326.34130,443View SEC Filing Icon  
1/4/2024Terry L MurdockCOOSell721$2.94$2,119.74103,638View SEC Filing Icon  
1/3/2024Rajesh MalikInsiderSell3,019$3.12$9,419.28170,659View SEC Filing Icon  
1/2/2024John E (Jack) Bailey, Jr.CEOSell32,983$3.27$107,854.41400,580View SEC Filing Icon  
12/11/2023Rajesh MalikInsiderSell33,839$3.41$115,390.99136,378View SEC Filing Icon  
7/5/2023Andrew PerryInsiderSell355$2.45$869.7555,945View SEC Filing Icon  
7/5/2023John E (Jack) Bailey, Jr.CEOSell2,719$2.45$6,661.55433,563View SEC Filing Icon  
7/5/2023Terry L MurdockCOOSell1,361$2.45$3,334.4570,078View SEC Filing Icon  
1/5/2023Terry L MurdockCOOSell729$5.41$3,943.8936,439View SEC Filing Icon  
1/4/2023Andrew PerryInsiderSell820$5.58$4,575.6021,300View SEC Filing Icon  
1/4/2023Jennifer K MosesCFOSell1,639$5.58$9,145.6258,549View SEC Filing Icon  
1/3/2023John E (Jack) Bailey, Jr.CEOSell32,019$5.85$187,311.15281,889View SEC Filing Icon  
10/18/2022Mark A. VellecaDirectorSell15,000$11.70$175,500.00116,000View SEC Filing Icon  
9/20/2022Mark A. VellecaDirectorSell20,000$13.50$270,000.00116,000View SEC Filing Icon  
9/13/2022Rajesh MalikInsiderSell18,000$15.71$282,780.0073,207View SEC Filing Icon  
8/16/2022Mark A. VellecaDirectorSell80,000$12.64$1,011,200.00116,000View SEC Filing Icon  
7/5/2022Terry L MurdockCOOSell648$5.17$3,350.1620,907View SEC Filing Icon  
1/5/2022James Stillman HansonGeneral CounselSell1,445$10.61$15,331.45View SEC Filing Icon  
1/3/2022John E (Jack) Bailey, Jr.CEOSell34,125$10.41$355,241.25View SEC Filing Icon  
7/15/2021Mark A. VellecaDirectorSell10,000$18.49$184,900.0071,000View SEC Filing Icon  
7/13/2021Mark A. VellecaDirectorSell10,000$19.45$194,500.0071,000View SEC Filing Icon  
6/17/2021Mark A. VellecaDirectorSell10,000$21.77$217,700.0071,000View SEC Filing Icon  
6/15/2021Mark A. VellecaDirectorSell10,000$22.39$223,900.0071,000View SEC Filing Icon  
5/13/2021Mark A. VellecaDirectorSell30,000$19.90$597,000.00
5/11/2021Mark A. VellecaDirectorSell10,000$19.10$191,000.0051,000View SEC Filing Icon  
4/22/2021Rajesh MalikInsiderSell15,000$22.07$331,050.00View SEC Filing Icon  
4/14/2021Mark A. VellecaDirectorSell10,000$24.53$245,300.0051,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for G1 Therapeutics (NASDAQ:GTHX)

24.21% of G1 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GTHX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

G1 Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.1,981,673$6.04M0.0%+1.6%3.796%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.11,462$35K0.0%-29.6%0.022%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC44,726$0.14M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP26,017$79K0.0%+34.3%0.050%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.1,981,673$6.04M0.0%+1.6%3.823%Search for SEC Filing on Google Icon
2/15/2024Needham Investment Management LLC180,000$0.55M0.1%-23.1%0.347%Search for SEC Filing on Google Icon
2/15/2024Bridgeway Capital Management LLC120,000$0.37M0.0%-14.3%0.231%Search for SEC Filing on Google Icon
2/15/2024Birchview Capital LP80,000$0.24M0.2%-33.3%0.154%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp125,524$0.38M0.0%+26.4%0.242%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.11,462$35K0.0%-29.6%0.022%Search for SEC Filing on Google Icon
2/13/2024FinTrust Capital Advisors LLC100,780$0.31M0.1%+154,946.2%0.194%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC25,000$76K0.0%N/A0.048%Search for SEC Filing on Google Icon
2/9/2024Cambridge Investment Research Advisors Inc.11,811$36K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/8/2024Level Four Advisory Services LLC178,600$0.55M0.0%-2.6%0.345%Search for SEC Filing on Google Icon
2/8/2024Financial Advocates Investment Management12,950$39K0.0%N/A0.025%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP76,666$0.23M0.0%+3.0%0.148%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC34,400$0.11M0.0%N/A0.066%Search for SEC Filing on Google Icon
2/5/2024Choreo LLC35,234$0.11M0.0%N/A0.068%Search for SEC Filing on Google Icon
1/31/2024abrdn plc423,869$1.29M0.0%N/A0.818%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC121,800$0.37M0.1%-18.1%0.235%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.33,719$0.10M0.0%-22.4%0.065%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates565,555$1.73M0.0%-38.9%1.091%Search for SEC Filing on Google Icon
1/10/2024Creative Financial Designs Inc. ADV35,280$0.11M0.0%+98.1%0.068%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.573,256$0.83M0.0%+16.3%1.106%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP19,366$28K0.0%-92.7%0.037%Search for SEC Filing on Google Icon
11/15/2023Ameriprise Financial Inc.38,050$55K0.0%-70.1%0.073%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.204,200$0.29M0.0%+68.3%0.394%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC68,100$98K0.0%N/A0.131%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC131,585$0.19M0.0%N/A0.254%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.21,516$31K0.0%-91.0%0.042%Search for SEC Filing on Google Icon
11/6/2023Curi Wealth Management LLC70,742$0.10M0.0%+17.8%0.137%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates925,776$1.33M0.0%+16.9%1.789%Search for SEC Filing on Google Icon
10/20/2023Denali Advisors LLC148,800$0.21M0.1%+121.8%0.288%Search for SEC Filing on Google Icon
10/10/2023Franklin Street Advisors Inc. NC83,400$0.12M0.0%+142.4%0.161%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP150,437$0.38M0.0%-50.0%0.291%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd109,848$0.27M0.0%-62.7%0.212%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd22,855$57K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.96,116$0.24M0.0%+56.8%0.186%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 34,550$86K0.0%+310.2%0.067%Search for SEC Filing on Google Icon
8/14/2023Two Sigma Securities LLC12,587$31K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC17,400$43K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP55,600$0.14M0.0%-92.7%0.107%Search for SEC Filing on Google Icon
8/14/2023State Street Corp161,106$0.40M0.0%-18.7%0.311%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.55,805$0.14M0.0%N/A0.108%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC571,791$1.42M0.0%+29.1%1.105%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.1,185,645$2.95M0.0%-14.5%2.291%Search for SEC Filing on Google Icon
8/11/2023Financial Engines Advisors L.L.C.15,107$38K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC431,652$1.08M0.0%-1.5%0.834%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.2,115,873$5.27M0.0%-1.6%4.089%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp99,713$0.25M0.0%-19.9%0.193%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.239,609$0.60M0.0%+17.2%0.463%Search for SEC Filing on Google Icon
8/8/2023Fisher Asset Management LLC2,543,006$6.33M0.0%-6.7%4.914%Search for SEC Filing on Google Icon
7/31/2023Curi Wealth Management LLC60,042$0.15M0.0%-25.9%0.116%Search for SEC Filing on Google Icon
7/26/2023Creative Financial Designs Inc. ADV17,505$44K0.0%+60.6%0.034%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates792,114$1.97M0.0%+6.0%1.533%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC31,443$78K0.0%N/A0.061%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC67,100$0.17M0.1%N/A0.130%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC31,443$78K0.0%N/A0.061%Search for SEC Filing on Google Icon
6/5/2023Level Four Advisory Services LLC86,500$0.23M0.0%N/A0.167%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.149,805$0.40M0.0%+28.7%0.290%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.2,149,526$5.76M0.0%+5.6%4.161%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC56,040$0.15M0.0%-57.6%0.108%Search for SEC Filing on Google Icon
5/16/2023State Street Corp198,166$0.53M0.0%+10.3%0.384%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC27,455$74K0.0%-44.3%0.053%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC438,394$1.18M0.0%+23.7%0.849%Search for SEC Filing on Google Icon
5/16/2023AQR Capital Management LLC277,106$0.74M0.0%N/A0.536%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC154,266$0.41M0.0%+110.4%0.299%Search for SEC Filing on Google Icon
5/15/2023Bayesian Capital Management LP29,558$79K0.0%N/A0.057%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP274,200$0.74M0.0%-14.3%0.531%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP103,783$0.28M0.0%-74.3%0.201%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD17,755$48K0.0%-62.5%0.034%Search for SEC Filing on Google Icon
5/15/2023Boothbay Fund Management LLC26,300$70K0.0%+73.5%0.051%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd294,292$0.79M0.2%+187.7%0.570%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC442,975$1.19M0.0%-31.5%0.857%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.1,386,898$3.72M0.0%-7.1%2.685%Search for SEC Filing on Google Icon
5/12/2023BNP Paribas Arbitrage SNC63,487$0.17M0.0%+81.3%0.123%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE603,418$1.62M0.0%+135.4%1.168%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP144,780$0.39M0.0%+35.0%0.280%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP89,133$0.24M0.0%-75.8%0.173%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.204,364$0.55M0.0%+11.6%0.396%Search for SEC Filing on Google Icon
5/11/2023FMR LLC964,592$2.59M0.0%+246.3%1.867%Search for SEC Filing on Google Icon
5/11/2023Envestnet Asset Management Inc.16,369$44K0.0%+57.5%0.032%Search for SEC Filing on Google Icon
5/10/2023Landscape Capital Management L.L.C.38,569$0.10M0.0%-31.3%0.075%Search for SEC Filing on Google Icon
5/10/2023Credit Suisse AG38,602$0.10M0.0%+11.6%0.075%Search for SEC Filing on Google Icon
5/10/2023Swiss National Bank92,600$0.25M0.0%-10.5%0.179%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.16,513$44K0.0%N/A0.032%Search for SEC Filing on Google Icon
5/8/2023Zurcher Kantonalbank Zurich Cantonalbank12,135$33K0.0%N/A0.023%Search for SEC Filing on Google Icon
5/1/2023Fisher Asset Management LLC2,724,710$7.30M0.0%-3.0%5.274%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC39,214$0.11M0.0%-16.6%0.076%Search for SEC Filing on Google Icon
4/14/2023Raymond James & Associates747,411$2M0.0%+49.8%1.447%Search for SEC Filing on Google Icon
4/12/2023Franklin Street Advisors Inc. NC33,160$89K0.0%+43.2%0.064%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC132,124$0.72M0.0%+41.0%0.308%Search for SEC Filing on Google Icon
2/15/2023Lazard Asset Management LLC10,012$54K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board42,951$0.23M0.0%N/A0.100%Search for SEC Filing on Google Icon
2/15/2023Laurion Capital Management LP200,000$1.09M0.0%N/A0.466%Search for SEC Filing on Google Icon
2/15/2023Legal & General Group Plc11,571$63K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/15/2023Mackenzie Financial Corp77,450$0.42M0.0%N/A0.180%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC1,671,859$9.08M0.0%+42.6%3.896%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley370,673$2.01M0.0%+9.6%0.864%Search for SEC Filing on Google Icon
2/15/2023Man Group plc23,760$0.13M0.0%N/A0.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
G1 Therapeutics logo
G1 Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor can protect bone marrow and reduce hematologic adverse events (AEs), as well as improve emerging treatments through myeloprotection which improve patients' overall anti-tumor immune responses combination with the antibody-drug conjugate; and treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat any indication in humans, as well as Nanjing Simcere Dongyuan Pharmaceutical Co., LTD. for the development and commercialization of trilaciclib for any indication in humans through parenteral delivery, and ARC Therapeutics for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.
Read More on G1 Therapeutics

Today's Range

Now: $4.49
Low: $4.34
High: $4.66

50 Day Range

MA: $3.48
Low: $2.10
High: $4.83

52 Week Range

Now: $4.49
Low: $1.08
High: $5.00

Volume

395,379 shs

Average Volume

1,463,462 shs

Market Capitalization

$234.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of G1 Therapeutics?

G1 Therapeutics' top insider shareholders include:
  1. John E (Jack) Jr Bailey (CEO)
  2. Rajesh Malik (Insider)
  3. John W V Umstead (CFO)
  4. Mark A Velleca (Director)
  5. Terry L Murdock (COO)
  6. Jennifer K Moses (CFO)
  7. Andrew Perry (Insider)
Learn More about top insider investors at G1 Therapeutics.

Who are the major institutional investors of G1 Therapeutics?

G1 Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 3.82%
  2. Vanguard Group Inc. — 3.80%
  3. Raymond James & Associates — 1.09%
  4. abrdn plc — 0.82%
  5. Needham Investment Management LLC — 0.35%
  6. Level Four Advisory Services LLC — 0.34%
Learn More about top institutional investors of G1 Therapeutics stock.

Which institutional investors are selling G1 Therapeutics stock?

During the last quarter, GTHX stock was sold by these institutional investors:
  1. Raymond James & Associates
  2. Needham Investment Management LLC
  3. Birchview Capital LP
  4. Denali Advisors LLC
  5. Bridgeway Capital Management LLC
  6. Raymond James Financial Services Advisors Inc.
  7. Goldman Sachs Group Inc.
  8. Goldman Sachs Group Inc.
Within the previous year, company insiders that have sold G1 Therapeutics company stock include:
  1. John E (Jack) Jr Bailey (CEO)
  2. Rajesh Malik (Insider)
  3. John W V Umstead (CFO)
  4. Mark A Velleca (Director)
  5. Terry L Murdock (COO)
Learn More investors selling G1 Therapeutics stock.

Which institutional investors are buying G1 Therapeutics stock?

Within the previous quarter, GTHX stock was purchased by institutional investors including:
  1. abrdn plc
  2. FinTrust Capital Advisors LLC
  3. Virtu Financial LLC
  4. Simplex Trading LLC
  5. Choreo LLC
  6. Jump Financial LLC
  7. Vanguard Group Inc.
  8. Vanguard Group Inc.